Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Our commitment to compliance is a key component of our business strategy. It starts at the top, with leaders setting expectations around honesty and integrity in our business relationships with patients, customers, suppliers, the government, and other payors, as well as fellow employees, investors, and the general public.
We have adopted a Code of Ethics and Business Conduct that requires all employees to comply with all applicable laws, regulations, and rules. To assist us in meeting this commitment, our Compliance Program is focused on key healthcare risk areas, with dedicated ethics and compliance officers partnering with business leaders and a robust compliance monitoring function.
Notice: California Health and Safety Code 119402
On September 29, 2004, California Governor Arnold Schwarzenegger signed into effect California Health and Safety Code §119402, requiring pharmaceutical companies, including us, to adopt comprehensive compliance programs (CCPs) relating to their interactions with healthcare professionals (HCPs). The statute requires that the CCPs must be in accordance with both the PhRMA Code and with the guidance issued by the Office of Inspector General (OIG) within the United States Department of Health and Human Services. The statute also requires each pharmaceutical company to:
Click the links in the “General compliance documents” section below to access our Code of Business Conduct and the 2015 Annual Declaration of Compliance. If you are unable to print the documents, requests for copies can be made by calling 1-800-662-1237, ext. 9099.
GENERAL COMPLIANCE DOCUMENTS
Declaration of compliance - Fresenius Medical Care North America compliance declaration
Code of business conduct - Fresenius Medical Care North America compliance program
Notice of privacy practices - How medical information about you may be used and disclosed, and how you can get access to this information
Vendor relationships policy - Compliance standards for Fresenius Medical Care vendors, suppliers, and contractors
DEFICIT REDUCTION ACT
Deficit Reduction Act (DRA) Policy - Compliance with Applicable Federal and State Laws—False Claims Acts and Similar Laws
State Law Summary - State-by-state summary of False Claim Acts, and other state fraud and false statement laws related to healthcare items and services
Financial Conflict of Interest - Clinical Research Policy
Verified-Accredited Wholesale Distributors (VAWD) Accreditation - VAWD is an accreditation for pharmaceutical wholesale distribution facilities. It plays a key role in preventing counterfeit drugs from entering the United States’ drug supply. We achieved accreditation as a wholesale distributor that is in compliance with state and federal laws and VAWD criteria and proudly display the VAWD Seal.